FILE – In an Oct. 5, 2005 report picture other people stroll via a Boots pharmacy in central London. Drugstore chain Walgreen Co. says it’ll spend $6.7 billion to shop for a stake in beauty and health store Alliance Boots. (AP Picture/Sergio Dionisio)
Sergio Dionisio
Walgreens Boots Alliance CEO Roz Brewer stated Tuesday that the store has begun a strategic evaluate of its Boots trade.
In a digital presentation on the J.P. Morgan Healthcare Convention, Brewer showed that the corporate is thinking about the right way to continue with the U.Okay.-based drugstore chain. She didn’t say whether or not that may be a sale and, if that is so, who may well be the patron.
“Whilst the method is at an exploratory degree, we do be expecting to transport temporarily,” she stated.
Walgreens has been reportedly taking into consideration a sale, because it ramps up its center of attention on well being care and competes with U.S. rival CVS Well being. Previous Tuesday, British information outlet Sky Information reported that non-public fairness companies Bain Capital and CVC Capital Companions had been hanging in combination a bid for Boots. It cited unnamed resources and Walgreens didn’t remark at the file.
Boots has greater than 2,200 shops and kind of 51,000 workers, in line with the corporate’s website online. It additionally has masses of optical practices and listening to care places. At the side of promoting drugstore pieces, it’s recognized for good looks manufacturers, together with its personal labels like No7 and Cleaning soap & Glory, that have been picked up via main outlets like Ulta Attractiveness and Walmart.
Stocks of Walgreens closed at $54.33 on Tuesday, up 1.12% and are up about 14% during the last twelve months.
